Display options
Cite
Chamberlain AT, Seib K, Ault KA, et al. Factors Associated with Intention to Receive Influenza and Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccines during Pregnancy: A Focus on Vaccine Hesitancy and Perceptions of Disease Severity and Vaccine Safety. PLoS Curr. 2015;7doi: 10.1371/currents.outbreaks.d37b61bceebae5a7a06d40a301cfa819.
Chamberlain, A. T., Seib, K., Ault, K. A., Orenstein, W. A., Frew, P. M., Malik, F., Cortés, M., Cota, P., Whitney, E. A., Flowers, L. C., Berkelman, R. L., & Omer, S. B. (2015). Factors Associated with Intention to Receive Influenza and Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccines during Pregnancy: A Focus on Vaccine Hesitancy and Perceptions of Disease Severity and Vaccine Safety. PLoS currents, 7. https://doi.org/10.1371/currents.outbreaks.d37b61bceebae5a7a06d40a301cfa819
Chamberlain, Allison T, et al. "Factors Associated with Intention to Receive Influenza and Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccines during Pregnancy: A Focus on Vaccine Hesitancy and Perceptions of Disease Severity and Vaccine Safety." PLoS currents vol. 7 (2015). doi: https://doi.org/10.1371/currents.outbreaks.d37b61bceebae5a7a06d40a301cfa819
Chamberlain AT, Seib K, Ault KA, Orenstein WA, Frew PM, Malik F, Cortés M, Cota P, Whitney EA, Flowers LC, Berkelman RL, Omer SB. Factors Associated with Intention to Receive Influenza and Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccines during Pregnancy: A Focus on Vaccine Hesitancy and Perceptions of Disease Severity and Vaccine Safety. PLoS Curr. 2015 Feb 25;7. doi: 10.1371/currents.outbreaks.d37b61bceebae5a7a06d40a301cfa819. PMID: 25789203; PMCID: PMC4353696.
Copy Download .nbib Format: NLM
Share it on

PLoS Curr. 2015 Feb 25;7. doi: 10.1371/currents.outbreaks.d37b61bceebae5a7a06d40a301cfa819.

Factors Associated with Intention to Receive Influenza and Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccines during Pregnancy: A Focus on Vaccine Hesitancy and Perceptions of Disease Severity and Vaccine Safety.

PLoS currents

Allison T Chamberlain, Katherine Seib, Kevin A Ault, Walter A Orenstein, Paula M Frew, Fauzia Malik, Marielysse Cortés, Pat Cota, Ellen A S Whitney, Lisa C Flowers, Ruth L Berkelman, Saad B Omer

Affiliations

  1. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
  2. Department of Medicine, Division of Infectious Disease, Emory University, Atlanta, Georgia, USA.
  3. Department of Gynecology and Obstetrics, School of Medicine, Emory University, Atlanta, GA, USA; Department of Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City, KS, USA.
  4. Department of Medicine, Division of Infectious Disease, Emory University, Atlanta, Georgia, USA; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.
  5. Department of Medicine, Division of Infectious Disease, Emory University, Atlanta, Georgia, USA; Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
  6. Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
  7. Georgia Obstetrical and Gynecological Society, Suwannee, Georgia, USA.
  8. Department of Gynecology and Obstetrics, Emory University, Atlanta, Georgia, USA.
  9. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA; 6 Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

PMID: 25789203 PMCID: PMC4353696 DOI: 10.1371/currents.outbreaks.d37b61bceebae5a7a06d40a301cfa819

Abstract

BACKGROUND: Improving influenza and tetanus, diphtheria and acellular pertussis (Tdap) vaccine coverage among pregnant women is needed.

PURPOSE: To assess factors associated with intention to receive influenza and/or Tdap vaccinations during pregnancy with a focus on perceptions of influenza and pertussis disease severity and influenza vaccine safety.

METHODS: Participants were 325 pregnant women in Georgia recruited from December 2012 - April 2013 who had not yet received a 2012/2013 influenza vaccine or a Tdap vaccine while pregnant. Women completed a survey assessing influenza vaccination history, likelihood of receiving antenatal influenza and/or Tdap vaccines, and knowledge, attitudes and beliefs about influenza, pertussis, and their associated vaccines.

RESULTS: Seventy-three percent and 81% of women believed influenza and pertussis, respectively, would be serious during pregnancy while 87% and 92% believed influenza and pertussis, respectively, would be serious to their infants. Perception of pertussis severity for their infant was strongly associated with an intention to receive a Tdap vaccine before delivery (p=0.004). Despite perceptions of disease severity for themselves and their infants, only 34% and 44% intended to receive antenatal influenza and Tdap vaccines, respectively. Forty-six percent had low perceptions of safety regarding the influenza vaccine during pregnancy, and compared to women who perceived the influenza vaccine as safe, women who perceived the vaccine as unsafe were less likely to intend to receive antenatal influenza (48% vs. 20%; p < 0.001) or Tdap (53% vs. 33%; p < 0.001) vaccinations.

CONCLUSIONS: Results from this baseline survey suggest that while pregnant women who remain unvaccinated against influenza within the first three months of the putative influenza season may be aware of the risks influenza and pertussis pose to themselves and their infants, many remain reluctant to receive influenza and Tdap vaccines antenatally. To improve vaccine uptake in the obstetric setting, our findings support development of evidence-based vaccine promotion interventions which emphasize vaccine safety during pregnancy and mention disease severity in infancy.

Keywords: Influenza; maternal vaccination; pertussis; vaccination; vaccine hesitancy

References

  1. Am J Obstet Gynecol. 2005 Apr;192(4):1098-106 - PubMed
  2. MMWR Morb Mortal Wkly Rep. 2013 Feb 22;62(7):131-5 - PubMed
  3. PLoS Med. 2011 May;8(5):e1000441 - PubMed
  4. Hum Vaccin. 2009 May;5(5):315-21 - PubMed
  5. N Engl J Med. 2008 Oct 9;359(15):1555-64 - PubMed
  6. Am J Epidemiol. 1998 Dec 1;148(11):1094-102 - PubMed
  7. Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S107-11 - PubMed
  8. Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S21-7 - PubMed
  9. Emerg Infect Dis. 2008 Jan;14(1):95-100 - PubMed
  10. Obstet Gynecol. 2013 Apr;121(4):897-903 - PubMed
  11. Obstet Gynecol. 2013 Jun;121(6):1411-4 - PubMed
  12. Womens Health Issues. 2002 Jul-Aug;12(4):165-77 - PubMed
  13. Pediatrics. 2008 Mar;121(3):484-92 - PubMed
  14. Obstet Gynecol. 2008 Apr;111(4):945-52 - PubMed
  15. Vaccine. 2010 Nov 23;28(50):8001-7 - PubMed
  16. Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S67-74 - PubMed
  17. MMWR Morb Mortal Wkly Rep. 2011 Oct 21;60(41):1424-6 - PubMed
  18. Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S58-63 - PubMed
  19. Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S9-16 - PubMed
  20. Vaccine. 2012 Jun 8;30(27):4055-9 - PubMed
  21. Emerg Infect Dis. 2006 Nov;12(11):1638-43 - PubMed
  22. Am J Obstet Gynecol. 2011 Feb;204(2):146.e1-7 - PubMed
  23. CMAJ. 2007 Feb 13;176(4):463-8 - PubMed
  24. Pediatr Infect Dis J. 2013 May;32(5):431-5 - PubMed
  25. J Obstet Gynaecol Can. 2009 Feb;31(2):120-5 - PubMed
  26. Obstet Gynecol. 2013 Mar;121(3):503-4 - PubMed
  27. Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S33-7 - PubMed
  28. Am J Public Health Nations Health. 1961 Aug;51:1182-8 - PubMed
  29. Am J Obstet Gynecol. 2009 Dec;201(6):547-52 - PubMed
  30. Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S112-5 - PubMed
  31. Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S38-46 - PubMed
  32. Pediatr Infect Dis J. 1987 Apr;6(4):398-403 - PubMed
  33. MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62 - PubMed

Publication Types

Grant support